HM Capital

HM Capital invests across the full venture lifecycle, from seed and start-up rounds through expansion and late-stage growth. This stage-agnostic approach means the firm can deploy initial checks at formation and follow portfolio companies through subsequent funding rounds, a structure common among China-based venture firms that prize long-term founder relationships. The firm does not publicly differentiate its seed-stage and growth-stage teams or vehicles.

HM Capital has not publicly identified any sectors it explicitly excludes from its investment mandate. Its stated focus areas — enterprise software, AI/ML, digital health, and industrial technology — signal where the firm concentrates its sourcing and underwriting resources, but the absence of negative sector flags suggests the partnership retains discretion to evaluate opportunities outside these areas in China's technology market.

HM Capital's deal-sourcing model is not publicly described, but the firm's Beijing headquarters positions it in China's densest concentration of technology founders, venture networks, and policy institutions. For China-based early-stage investors, sourcing typically depends on founder referrals, university spinout relationships, and proximity to state-backed incubation programs — structural advantages that Beijing-anchored firms exploit. Allocators would need direct conversations to understand HM Capital's specific origination funnel.

HM Capital has not publicly disclosed its fund currency or legal structure. Many Beijing-based private equity firms operate parallel RMB and USD vehicles, but no public filings, LP disclosures, or the firm's limited website content confirm the structure for HM Capital. Determining currency exposure and vehicle domicile would require direct due diligence with the firm.

HM Capital does not publicly list its investment committee members, managing partners, or senior investment professionals on its website or through public regulatory filings. The firm's leadership structure is not available from public record, which is not unusual for smaller, privately held Chinese asset managers that limit disclosure. Allocators would need to engage directly to assess decision-making authority and team composition.